Sathekge, M., Lawal, I. O., Bal, C., Bruchertseifer, F., Ballal, S., Cardaci, G., . . . Morgenstern, A. (2024). Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): A multicentre, retrospective study. The lancet. Oncology, 25(2), . https://doi.org/10.1016/S1470-2045(23)00638-1
Chicago-Zitierstil (17. Ausg.)Sathekge, Mike, et al. "Actinium-225-PSMA Radioligand Therapy of Metastatic Castration-resistant Prostate Cancer (WARMTH Act): A Multicentre, Retrospective Study." The Lancet. Oncology 25, no. 2 (2024). https://doi.org/10.1016/S1470-2045(23)00638-1.
MLA-Zitierstil (9. Ausg.)Sathekge, Mike, et al. "Actinium-225-PSMA Radioligand Therapy of Metastatic Castration-resistant Prostate Cancer (WARMTH Act): A Multicentre, Retrospective Study." The Lancet. Oncology, vol. 25, no. 2, 2024, https://doi.org/10.1016/S1470-2045(23)00638-1.